A Phase 1 interventional study of Socially Assistive Robot for Low Vision Rehabilitation in Low Vision, sponsored by University of California, Los Angeles. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-19.
Sponsored by University of California, Los Angeles · Phase 1, Interventional, and Supportive care
The aims of this exploratory research project are to customize, deploy and evaluate the preliminary efficacy of a socially assistive robot as a novel approach to motivate and encourage optimal, long-term use of new magnification devices for reading in individuals with vision loss. The goals are to promote patient acceptance, adherence and skills reinforcement to achieve proficiency in the use of the magnifier, in order to attempt to reduce visual disability while performing important daily activities, such as reading tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, all of which motivate the development of this complementary approach for the provision of additional support at home by the socially assistive robot.
98 studies on the registry are indexed under Vision, Low; 23 are open to participants now.
This study's planned enrollment of 20 is below the median of 60 across 78 interventional studies indexed under Vision, Low.
Browse Vision, Low studies →University of California, Los Angeles is the lead sponsor of 1,170 studies on the registry; 195 are open to participants now.
Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
One month after study entry, participants will receive the robot at home for two months, followed by a three month observation period without the robot.
Behavioral: Socially Assistive Robot for Low Vision Rehabilitation
Three months after study entry, participants will receive the robot at home for three months.
Behavioral: Socially Assistive Robot for Low Vision Rehabilitation
A socially assistive robot will be customized to engage in dialog and conversations to motivate and encourage optimal use of new magnification devices for reading at home by individuals with vision loss.
Activity Inventory
questionnaire; scores will be Rasch analyzed in logic units with higher or positive scores indicating less difficulty (i.e., improvement)
Time frame: change from 1 month post-enrollment to 2-3 months after receiving the socially assistive robot
MNread
reading test
Time frame: For Immediate robot: baseline, 1 month, 3 months, 6 months. For Delayed/Waitlist robot: baseline, 3 months, 6 months.
Sustained Silent Reading Test
reading test
Time frame: baseline and monthly for 6 months
Geriatric Depression Scale (GDS)
questionnaire; scale ranges from 0 to 15 with higher values indicating greater depression
Time frame: baseline and monthly for 6 months
PANAS
questionnaire; scale ranges from 10 to 50 with higher values indicating greater positive moods
Time frame: baseline and monthly for 6 months
Perceived Stress Scale
questionnaire; scale ranges from 0 to 56 with higher values indicating greater perceived stress
Time frame: baseline and monthly for 6 months
3-item UCLA Loneliness Scale
questionnaire; scale ranges from 3 to 9 with higher values indicating greater loneliness
Time frame: baseline and monthly for 6 months
Duke Social Support Index
questionnaire; scale ranges from 10 to 30 with higher values indicating greater social support
Time frame: baseline and monthly for 6 months
Almere
questionnaire; scale ranges from 41 to 205 with higher values indicating greater acceptance of robots
Time frame: 1 month post-enrollment and 2-3 months after receiving the socially assistive robot
Started Apr 2022 (actual). Primary completion is estimated for Feb 2025, 34 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Los Angeles →